JOURNAL DESCRIPTION
The Medical Radiology and Radiation Safety journal ISSN 1024-6177 was founded in January 1956 (before December 30, 1993 it was entitled Medical Radiology, ISSN 0025-8334). In 2018, the journal received Online ISSN: 2618-9615 and was registered as an electronic online publication in Roskomnadzor on March 29, 2018. It publishes original research articles which cover questions of radiobiology, radiation medicine, radiation safety, radiation therapy, nuclear medicine and scientific reviews. In general the journal has more than 30 headings and it is of interest for specialists working in thefields of medicine¸ radiation biology, epidemiology, medical physics and technology. Since July 01, 2008 the journal has been published by State Research Center - Burnasyan Federal Medical Biophysical Center of Federal Medical Biological Agency. The founder from 1956 to the present time is the Ministry of Health of the Russian Federation, and from 2008 to the present time is the Federal Medical Biological Agency.
Members of the editorial board are scientists specializing in the field of radiation biology and medicine, radiation protection, radiation epidemiology, radiation oncology, radiation diagnostics and therapy, nuclear medicine and medical physics. The editorial board consists of academicians (members of the Russian Academy of Science (RAS)), the full member of Academy of Medical Sciences of the Republic of Armenia, corresponding members of the RAS, Doctors of Medicine, professor, candidates and doctors of biological, physical mathematics and engineering sciences. The editorial board is constantly replenished by experts who work in the CIS and foreign countries.
Six issues of the journal are published per year, the volume is 13.5 conventional printed sheets, 88 printer’s sheets, 1.000 copies. The journal has an identical full-text electronic version, which, simultaneously with the printed version and color drawings, is posted on the sites of the Scientific Electronic Library (SEL) and the journal's website. The journal is distributed through the Rospechat Agency under the contract № 7407 of June 16, 2006, through individual buyers and commercial structures. The publication of articles is free.
The journal is included in the List of Russian Reviewed Scientific Journals of the Higher Attestation Commission. Since 2008 the journal has been available on the Internet and indexed in the RISC database which is placed on Web of Science. Since February 2nd, 2018, the journal "Medical Radiology and Radiation Safety" has been indexed in the SCOPUS abstract and citation database.
Brief electronic versions of the Journal have been publicly available since 2005 on the website of the Medical Radiology and Radiation Safety Journal: http://www.medradiol.ru. Since 2011, all issues of the journal as a whole are publicly available, and since 2016 - full-text versions of scientific articles. Since 2005, subscribers can purchase full versions of other articles of any issue only through the National Electronic Library. The editor of the Medical Radiology and Radiation Safety Journal in accordance with the National Electronic Library agreement has been providing the Library with all its production since 2005 until now.
The main working language of the journal is Russian, an additional language is English, which is used to write titles of articles, information about authors, annotations, key words, a list of literature.
Since 2017 the journal Medical Radiology and Radiation Safety has switched to digital identification of publications, assigning to each article the identifier of the digital object (DOI), which greatly accelerated the search for the location of the article on the Internet. In future it is planned to publish the English-language version of the journal Medical Radiology and Radiation Safety for its development. In order to obtain information about the publication activity of the journal in March 2015, a counter of readers' references to the materials posted on the site from 2005 to the present which is placed on the journal's website. During 2015 - 2016 years on average there were no more than 100-170 handlings per day. Publication of a number of articles, as well as electronic versions of profile monographs and collections in the public domain, dramatically increased the number of handlings to the journal's website to 500 - 800 per day, and the total number of visits to the site at the end of 2017 was more than 230.000.
The two-year impact factor of RISC, according to data for 2017, was 0.439, taking into account citation from all sources - 0.570, and the five-year impact factor of RISC - 0.352.
Medical Radiology and Radiation Safety. 2022. Vol. 67. № 6
DOI:10.33266/1024-6177-2022-67-6-44-50
M.L. Belyanin1, A.S. Podyablonsky1, 2, O.Yu. Borodin1, 2, 3, M.V. Belousov3,
E.N. Karpov2, V.D. Filimonov1, N.L. Shimanovskii4, W.Yu. Ussov1, 5
Synthesis and Preclinical Evaluation of Imaging Abilities of 99mТс-DTPA-GDOF
as a New Original Russian Hepatotropic Agent for Scintigraphy and SPECT Studies
1National Research Tomsk Polytechnic University, Tomsk, Russia
2Tomsk Regional Oncology Center, Tomsk, Russia
3Siberian State Medical University, Tomsk, Russia
4 N.I. Pirogov Russian National Research Medical University, Moscow, Russia
5Cardiology Research Institute, Tomsk National Research Medical Center, Tomsk, Russia
Contact person: Wladimir Yurievich Ussov, e-mail: This email address is being protected from spambots. You need JavaScript enabled to view it.
ABSTRACT
Purpose: Was to obtain a radiopharmaceutical (RPH) ‒ 99mTc bound with DTPA-GDOF (2-(2-carboxymethyl-(4-hexa-decyloxyphenyl-carbamoyl-methyl)-aminoethyl)-aminoethyl-(4-hexadecyl-oxyphenyl-carbamoyl methyl)-aminoacetic acid) and evaluate in an in vivo experiment on laboratory rats the possibility of using as hepatotropic RPH for scintigraphy and SPECT.
Material and methods: The synthesis of DTPA-GDOF was carried out according to the original method of M.L. Belyanin e.a. at the N.M. Kizhner Center of TPU, by the interaction of 4-hexadecyloxyaniline with diethylenetriaminopentaacetic acid (d-DTPA) anhydride in dimethylformamide medium. Then 2 mg of GDOF-DTPA powder was mixed with 0.5 ml of
5 % sodium bicarbonate solution and heated to 100 oC until completely dissolved. 2 mg of tin dichloride powder were added to the solution, stirred and incubated at 25 oC for at least 20 minutes. The resulting solution was mixed with 99mTc eluate with an activity of 3 MBq and incubated for 10 min at 25 oC. Control of the labelling efficiency of 99mTc with DTPA-GDOF was carried out by chromatography on paper, according to the method of Zimmer and Pavel (1977).
An in vivo study of the absorption kinetics of 99mTc-DTPA-GDOF was performed on male rats of the Wistar line
(n = 12) 300–350 g. 99mTc-DTPA-GDOF at a dosage of 0.025 mmol/kg, 3 MBq was injected into the femoral vein. All scans are performed using the SPECT/CT Siemens Symbia T. Dynamic planar study included recording 4 sec/frame for the first two minutes, 128 × 128 pixels, and then up to 20 min – as 15 s/frame, followed by a SPECT/CT of the whole body. The value of the fraction of extraction (retention) of RPH in the liver was calculated. The values of the organ accumulation of RPH were determined as the organ fraction of uptake of the agent relative to the total dose administered to the animal
Results. The labeling efficiency of DTPA-GDOF with 99mTc in fresh eluate of a standard molybdenum generator was in all cases more than 94 % (on average 95.6 ± 2.1 %, thus the proportion of free technetium was up to 4‒4.5 %). When storing 99mTc-DTPA-GDOF at room temperature on a shelf for up to 5 hours, the release of 99mTc-from the complex with DTPA-GDOF did not exceed 3.1 ± 0.3 %. The extraction fraction of 99mTc-DTPA-GDOF in the liver is as high as 0.78 ± 0.04. The fraction of the injected dose taken up by the liver is up to 70 % (68.9 ± 8.9). The quota of the spleen uptake is 14.1 ± 4.2 %. The level of accumulation of 99mTc-DTPA-GDOF in the liver was then maintained steadily without a significant decrease for up to 16‒18 hours.
Conclusion: The 99mTc-DTPA-GDOF complex is a original RFP, with a high 99mTc labeling efficiency, long-lasting stability after labelling, and providing in vivo highly specific long-term imaging of the liver and spleen with gamma scintigraphy and SPECT.
Keywords: liver, 99mTc-DTPA-GDOF, SPECT, Technetium–99m, radiopharmaceuticals, rats
For citation: Belyanin ML, Podyablonsky AS, Borodin OYu, Belousov MV, Karpov EN, Filimonov VD, Shimanovskii NL, Ussov WYu. Synthesis and Preclinical Evaluation of Imaging Abilities of 99mТс-DTPA-GDOF as a New Original Russian Hepatotropic Agent for Scintigraphy and SPECT Studies. Medical Radiology and Radiation Safety. 2022;67(6):44–50. (In Russian). DOI:10.33266/1024-6177-2022-67-6-44-50
References
1. Shabunin A.V., Karalkin A.V., Grekov D.N., Drozdov P.A. Hybrid Technology in Determination of Functioning Volume of Liver Before Major Resections. Meditsinskaya Vizualizatsiya = Medical Visualization. 2015;4:39-45 (In Russ.).
2. Samoylov A.S., Kodina G.Ye., Larenkov A.A. Design and Implementation of New Types of Radiopharmaceuticals. Meditsina: Tselevyye Proyekty. 2015;20:19-22 (In Russ.).
3. Kodina G.Ye., Kulakov V.N., Sheyno I.N. Rare Earth Elements in Nuclear Medicine (Review). Saratovskiy Nauchno-Meditsinskiy Zhurnal = Saratov Journal of Medical Scientific Research. 2014;10;4:849–858 (In Russ.).
4. Sannikov M.Yu., Borodin O.Yu., Belyanin M.L., Semichev Ye.V., Bushlanov P.S., Filimonov V.D., et al. Preclinical Evavaluation of GDOF-Mn-DTPA as Contrast Media Versus Gd-EOB-DTPA for Contrast Enhanced Magnetic Resonance Imaging . Izvestiya Vysshih Uchebnyh Zavedeniy. Fizika. 2015;58;12-2:79-84 (In Russ.).
5. Podyablonskiy A.S., Belyanin M.L., Borodin O.Yu., Belousov M.V., Brazovskiy K.S., Krivoshchekov S.V., et al. Paramagnetic Contrast Enhancement in MRI Imaging of Liver Using an Original Hepatotropic High-Affinity Agent GDOF-Mn-DTPA. Translyatsionnaya Meditsina = Translational Medicine. 2021;8;2:14-22. DOI 10.18705/2311-4495-2020-8-2-14-22 (In Russ.).
6. Usov V.Yu., Belyanin M.L., Filimonov V.D., Danilets M., Milto I.V., Vesnina Zh.V., et al. Theoretical Basis and Experimental Study of Complex of Manganese (II) with Haxamthyl Propilenamin-Oxime as Paramagnetic Contrast Agent for MR-Imaging of Malignant Tumors. Luchevaya Diagnostika i Terapiya = Diagnostic Radiology and Radiotherapy. 2019;2;10:42-49. DOI: 10.22328/2079-5343-2019-10-2-42-49 (In Russ.).
7. Usov V.Yu., Belyanin M.L., Churin A.A., Bezlepkin A.I., Borodin O.Yu., Zorkaltsev M.A., et al. Trans-1.2-Diaminocyclohexan-N,N,N’,N’-Tetraacetic Acid (DCTA) as Multimodal Chelator for MRI and Single Photon Emission Imaging Using Complexes with Mn(Cyclomang) and 99mTc (Cyclotech). Diagnosticheskaya i Interventsionnaya Radiologiya = Diagnostic and Interventional Radiology. 2020;14;3:91-100. DOI 10.25512/DIR.2020.14.3.10 (In Russ.).
8. Usov V.Yu., Filimonov V.D., Belyanin M.L., Bezlepkin A.I., Luchich M.A., Kovalenko A.Yu., et al. Synthesis, Quantum Chemistry Analysis and Pre-Clinical in Vivo Evaluation of Magnetic Resonance Imaging Abilities of Paramagnetic Manganese Complex with 2,3-Dimercaptosucinate (Succimang). Meditsinskaya Vizualizatsiya = Medical Visualization. 2019;23;3:133-143. DOI 10.24835/1607-0763-2019-3-133-143 (In Russ.).
9. Zimmer A.M., Pavel D.G. Rapid Miniaturized Chromatographic Quality Control Procedures for Tc-99m Radlopharmaceuticais. J. nucl. Med. 1977;18:1230-1233.
10. Bondareva I.B., Narkevich B.Ya. Identification of Radiopharmaceutical Transport Models in Functional Radionuclide Diagnosis. Мedical Radiology. 1991;36;5:36-39.
11. Touya J.J., Rahimian J., Grubbs D.E., Corbus H.F., Bennett L.R. A Noninvasive procedure for In Vivo Assay of a Lung Amine Endothelial Receptor. J. Nucl. Med. 1985;26:1302-1307.
12. Velichko S.A., Slonimskaya Ye.M., Ryannel Yu.E. Scintigraphic Assessment of Local 99mTc-MIBI Uptake in Breast Cancer. Meditsinskaya Radiologiya i Radiatsionnaya Bezopasnost = Medical Radiology and Radiation Safety. 1996;41;4:39-44 (In Russ.).
13. Panov V.O., Shimanovskiy N.L. Has the Stability of Gadolinium-Based Magnetic Resonance Contrast Media the Clinical Significance? Vestnik Rentgenologii i Radiologii = Journal of Radiology and Nuclear Medicine. 2016;97;4:243-256
(In Russ.).
14. Lindner T., Altmann A., Krämer S., Kleist C., Loktev A., Kratochwil C., et al. Design and Development of 99mTc-Labeled FAPI Tracers for SPECT Imaging and 188Re Therapy. J. Nucl. Med. 2020;61;10:1507-1513. doi: 10.2967/jnumed.119.239731.
PDF (RUS) Full-text article (in Russian)
Conflict of interest. The authors declare no conflict of interest.
Financing. The research was carried out with the support of RFBR Grant No. 20-315-90114.
Contribution. Article was prepared with equal participation of the authors.
Article received: 20.07.2022. Accepted for publication: 25.09.2022.